GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Humanigen Inc (STU:0KB1) » Definitions » Other Long Term Assets

Humanigen (STU:0KB1) Other Long Term Assets : €0.08 Mil (As of Mar. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Humanigen Other Long Term Assets?

Humanigen's other long-term assets for the quarter that ended in Mar. 2023 was €0.08 Mil.

Humanigen's quarterly other long-term assets declined from Sep. 2022 (€0.09 Mil) to Dec. 2022 (€0.08 Mil) but then stayed the same from Dec. 2022 (€0.08 Mil) to Mar. 2023 (€0.08 Mil).

Humanigen's annual other long-term assets increased from Dec. 2020 (€0.07 Mil) to Dec. 2021 (€0.08 Mil) and increased from Dec. 2021 (€0.08 Mil) to Dec. 2022 (€0.08 Mil).


Humanigen Other Long Term Assets Historical Data

The historical data trend for Humanigen's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Humanigen Other Long Term Assets Chart

Humanigen Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.06 0.07 0.08 0.08

Humanigen Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.09 0.09 0.08 0.08

Humanigen Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Humanigen (STU:0KB1) Business Description

Traded in Other Exchanges
N/A
Address
830 Morris Turnpike, 4th Floor, Short Hills, NJ, USA, 07078
Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. It has one segment, which is related to the development of pharmaceutical products.

Humanigen (STU:0KB1) Headlines

No Headlines